| Target's General Information |
| Target ID |
T39321 |
| Target Name |
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) |
| Synonyms |
Peptidyl-cysteine S-nitrosylase GAPDH; OK/SW-cl.12; GAPD; D-glyceraldehyde-3-phosphate dehydrogenase; CDABP0047 |
| Target Type |
Clinical trial |
| Gene Name |
GAPDH |
| Biochemical Class |
Aldehyde/oxo donor oxidoreductase |
| UniProt ID |
G3P_HUMAN |
| Target's Expression Profile in Disease Related Tissue between Patients and Normal People |
| Disease |
Lateral sclerosis |
| Tissue |
Cervical spinal cord |
| Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -0.21
Z-score: -0.24
P-value: 5.24E-01
|
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
| Target's Expression Profile across Various Tissues of Healthy Individual |
|
| References |
| REF 1 |
Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
|
| REF 2 |
NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.
|
